Product image of Ondansetron Sandoz (Ondansetron) supplied by GNH India

Ondansetron Sandoz

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetron Sandoz (Ondansetron)

Ondansetron, the active ingredient in Ondansetron Sandoz, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is employed to prevent and treat nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH India supplies Ondansetron Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron Sandoz is used to control nausea and vomiting by acting on the serotonergic pathways involved in emesis.

  • Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes.
  • Radiation‑induced nausea and vomiting: prevents onset of symptoms during and after radiotherapy.
  • Postoperative nausea and vomiting: helps maintain patient comfort and reduces the need for rescue antiemetics.

How It Works

  • Ondansetron selectively blocks serotonin (5‑HT3) receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting these receptors, it interrupts the signaling cascade that initiates the vomiting reflex, thereby providing antiemetic protection during chemotherapy, radiation, and surgery.

Side Effects

Ondansetron may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Diarrhoea: loose stools.
  • Dizziness: sensation of light‑headedness.
  • Fatigue: feeling unusually tired.
  • Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects

  • QT interval prolongation: may lead to cardiac arrhythmia.
  • Severe allergic reactions: rash, swelling, anaphylaxis.
  • Serotonin syndrome: agitation, hyperthermia, neuromuscular abnormalities.
  • Cardiac arrhythmia: irregular heart rhythm beyond QT changes.
  • Hepatic dysfunction: elevated liver enzymes.
  • Neutropenia: reduced white blood cell count.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

  • Cardiac assessment: review history of arrhythmias or prolonged QT.
  • Electrolyte monitoring: correct hypokalaemia or hypomagnesaemia.
  • Hepatic impairment: adjust use in patients with liver disease.
  • Concomitant QT‑prolonging drugs: avoid or monitor closely.
  • Renal function: consider dose adjustment in severe renal insufficiency.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ondansetron interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Apomorphine: may cause profound hypotension.
  • Other QT‑prolonging agents (e.g., quinidine, erythromycin): increase risk of cardiac arrhythmia.
  • Carbamazepine: induces metabolism, reducing ondansetron efficacy.
  • Aprepitant: CYP3A4 interaction may alter plasma levels.
  • Ritonavir: strong CYP3A4 inhibitor, may raise ondansetron concentrations.

Moderate Interactions (Monitor Closely)

  • SSRIs/SNRIs: combined use can precipitate serotonin syndrome.
  • Ketoconazole: may increase ondansetron exposure.
  • Phenytoin: may lower ondansetron levels.
  • Digoxin: potential increase in serum digoxin.
  • Warfarin: possible effect on INR, requiring monitoring.

Frequently Asked Questions

Ondansetron Sandoz is an antiemetic medication used to prevent and treat nausea and vomiting that result from chemotherapy, radiation therapy, and surgical procedures. It helps improve patient comfort and reduces the need for additional rescue medications during these treatments.

Ondansetron works by selectively blocking serotonin type 3 (5‑HT3) receptors located on the vagus nerve terminals in the gut and in the chemoreceptor trigger zone of the brain. This inhibition stops the signaling that triggers the vomiting reflex, providing effective control of nausea.

The dosage of ondansetron is individualized by the prescribing clinician based on the indication, patient age, weight, and renal or hepatic function. Healthcare professionals determine the appropriate strength, frequency, and duration of therapy for each patient.

Ondansetron is classified as Pregnancy Category B in many regions, indicating no proven risk in animal studies but limited human data. It should be used during pregnancy only if clearly needed. Small amounts are excreted in breast milk; nursing mothers should discuss risks and benefits with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ondansetron, a 5‑HT3 antagonist, offers rapid and specific control of nausea and vomiting with fewer extrapyramidal side effects than dopamine antagonists such as metoclopramide. It is generally more effective for chemotherapy‑induced emesis, while other agents may be preferred for different mechanisms or when cost is a primary concern.

Ondansetron Sandoz tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Ondansetron Sandoz is administered orally as a tablet, typically with or without food. In some clinical settings, a liquid formulation or intravenous injection may be used, but the tablet form is taken by swallowing the tablet whole with a glass of water.

The most serious risks include QT interval prolongation leading to potentially life‑threatening cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic drugs. Patients should be monitored for cardiac symptoms and signs of hypersensitivity.

Ondansetron should be avoided in patients with known hypersensitivity to the drug or any of its components, those with congenital long QT syndrome, or individuals taking other medications that significantly prolong the QT interval. Caution is also advised for patients with severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT